BRIEF-Abbvie To Acquire Gilgamesh Pharmaceuticals' Bretisilocin-March 2024-www.financetom.com

BRIEF-Abbvie To Acquire Gilgamesh Pharmaceuticals' Bretisilocin

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Abbvie To Acquire Gilgamesh Pharmaceuticals' Bretisilocin

Aug 25, 2025 6:38 AM

Aug 25 (Reuters) - Abbvie Inc ( ABBV ):

* ABBVIE TO ACQUIRE GILGAMESH PHARMACEUTICALS' BRETISILOCIN,

NOVEL, INVESTIGATIONAL THERAPY FOR MAJOR DEPRESSIVE DISORDER,

EXPANDING PSYCHIATRY PIPELINE

* ABBVIE INC ( ABBV ) - TO BUY BRETISILOCIN PROGRAM FOR UP TO $1.2

BILLION

* ABBVIE ( ABBV ) - GILGAMESH WILL SPIN OFF A NEW ENTITY THAT WILL

OPERATE

UNDER NAME GILGAMESH PHARMA INC

Source text:

Further company coverage:

Previous page： Smartsheet Stock Rise After Higher Q1 Non-GAAP Earnings, Revenue Next page： Five Below Stock Drops After Q1 Results: Here's Why

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Smartsheet Stock Rise After Higher Q1 Non-GAAP Earnings, Revenue

Jun 5, 2024

04:46 PM EDT, 06/05/2024 (MT Newswires) -- Smartsheet ( SMAR ) was up 10% in Wednesday's extended session after reporting Q1 non-GAAP earnings of $0.32 per diluted share, up from $0.18 a year earlier. Analysts polled by Capital IQ expected $0.27. Revenue for the quarter ended April 30 was $263 million, up from $219.9 million a year earlier. Analysts expected...

Five Below Stock Drops After Q1 Results: Here's Why

Jun 5, 2024

Five Below, Inc. ( FIVE ) shares are down after the company reported its first-quarter financial results Wednesday. Here's a look at the details in the report. The Details: Five Below ( FIVE ) reported quarterly earnings of 60 cents per share which missed the analyst consensus estimate of 63 cents by 4.76% and represents a 10.45% decrease from the...

Stepstone Group Insider Sold Shares Worth $316,725, According to a Recent SEC Filing

Jun 5, 2024

04:47 PM EDT, 06/05/2024 (MT Newswires) -- Thomas Keck, Director, on June 03, 2024, sold 7,035 shares in Stepstone Group ( STEP ) for $316,725. Following the Form 4 filing with the SEC, Keck has control over a total of 4,449,372 shares of the company, with 9,159 shares held directly and 4,440,213 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1796022/000179602224000051/xslF345X03/wk-form4_1717620230.xml ...

Atlassian Insider Sold Shares Worth $1,310,659, According to a Recent SEC Filing

Jun 5, 2024

04:48 PM EDT, 06/05/2024 (MT Newswires) -- Scott Farquhar, 10% Owner, Director, Co-CEO, Co-Founder, on June 04, 2024, sold 8,241 shares in Atlassian ( TEAM ) for $1,310,659. Following the Form 4 filing with the SEC, Farquhar has control over a total of 135,702 shares of the company, with 135,702 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024004705/xslF345X03/primarydocument.xml Price: 157.86, Change: -0.02, Percent...